Accrued other expenses consisted of the following amounts (in thousands):
As of September 30,
As of December 31,
2026
2025
Accrued research and development costs
$
4,903
7,161
Deferred income – transition services agreement (TSA) performance obligation, current portion
5,180
—
Accrued other
5,653
759
Total accrued other expenses
15,736
7,920
No definition available.
Tabular disclosure of the components of accrued liabilities.